Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
, characterization and optimization of molecules with drug-like properties, and the development of novel therapeutic concepts. The group follows a highly integrated and multidisciplinary approach, including drug
-
team, capable to work independently, and stay committed for at least a year. With a service-oriented mindset and the ability to follow instructions, they are proactive in asking questions and developing
-
mentoring programme. Support the development and implementation of training and capacity building of relevant stakeholder groups. Engage with various stakeholders from the private and public sectors as
-
develop new therapies for vision loss. It is a place where your expertise will be valued, your abilities challenged, and your knowledge expanded. We are seeking qualified and highly motivated Research
-
evaluation of the candidates' activities during the first six months. Your position The scholarships are meant to support graduates in the early stages of their PhD, during which they will develop research
-
Your position These one-year positions are intended as an opportunity for postdocs to develop their own research project using the Futures Interrupted approach. They will be supported in their grant
-
Chemistry with a relation to cancer research and immunobiology. The candidate will join our multi-disciplinary teams and focus on the development of novel modalities to target the PI3K-mTOR pathway
-
disease and to develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 800 employees, the Department of Biomedicine is the largest
-
part of the National Research Program NRP83. The goal of the project is to identify, understand, and mitigate gender and sex biases in implantable medical devices, to promote equitable healthcare
-
experience. IOB is a research institute combining basic and clinical research. Its mission is to drive innovations in understanding vision and its diseases and develop new therapies for vision loss. It is a